Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Concordia Healthcare Corp. T.CXR.R

TSX:CXR.R - Post Discussion

Concordia Healthcare Corp. > our $100 CXR by the end of this year or 2016?
View:
Post by healthstock1234 on Nov 09, 2015 4:49pm

our $100 CXR by the end of this year or 2016?

https://blogs.wsj.com/moneybeat/2015/10/26/from-worst-to-first-deutsche-bank-says-health-care-stocks-will-be-back-on-top-in-2016/
Comment by TheRock07 on Nov 09, 2015 8:51pm
No doubt about that prediction. Healthcare is $3.2 trillion, the largest (18%) business in the US.
Comment by healthstock1234 on Nov 09, 2015 8:54pm
I think that they can not import drugs only because the price is under drugs-American market. We have some standards of quality ,here.
Comment by Marcel7 on Nov 09, 2015 9:07pm
Sorry healthstock1234, I have no idea what you are trying to say here. Can you clarify?
Comment by healthstock1234 on Nov 09, 2015 9:23pm
The link today about the healthcare market and  I posted yesterday this: drug price reduction -solution?! Import?!My God!!-I do prefer North American drugs with USDA certification! https://www.washingtontimes.com/news/2015/nov/8/gil-gutknecht-addressing-high-drug-prices/ We need to open the American pharmaceutical market, create real competition and level the playing field with ...more  
Comment by healthstock1234 on Nov 09, 2015 9:25pm
today, you have this link: https://blogs.wsj.com/moneybeat/2015/10/26/from-worst-to-first-deutsche-bank-says-health-care-stocks-will-be-back-on-top-in-2016/
Comment by Scruggstyle on Nov 09, 2015 9:41pm
No kidding.   
Comment by healthstock1234 on Nov 09, 2015 9:43pm
In fact will be $145 or more.
Comment by pineapple1 on Nov 09, 2015 9:57pm
This post has been removed in accordance with Community Policy
Comment by Slinger14 on Nov 09, 2015 10:10pm
Well pineapple, it dropped from $117 to $25 in a couple months and is now extremely undervalued. While it may not jump to $145 in a year, it doesn't seem too far-fetched for it to increase 3.5 times when it was already triple what it was now with approximately 1/2 current earnings.
Comment by Scruggstyle on Nov 09, 2015 10:11pm
No.  I replied to Marcel7.
Comment by Pj1958 on Nov 09, 2015 11:02pm
We may need to wait till Q4 results in Feb of  2016 to see $145, but we could see $75 or so by Christmas. The Q4 results will have the full AMCo acquisition revenue , and it will look better than forecast , as Thompson's forecast was a little cautious. It's called under promise and over deliver.
Comment by notwrong on Nov 10, 2015 12:43am
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities